港股创新药概念大幅回调，机构称中国创新药产业迎来价值重估

Group 1 - The Hong Kong stock market indices collectively rose on August 7, with mixed performance in tech stocks, while Apple-related stocks led the gains [1] - The newly listed Hong Kong Stock Connect Medical ETF (520510) experienced fluctuations, dropping over 1% at one point, with most holdings declining [1] - The report from Minyin International highlighted that domestic medical insurance policies and overseas value recognition will support the ongoing trend in China's innovative drug market [1] Group 2 - The Hong Kong Stock Connect Medical ETF (520510) tracks the Hong Kong Stock Connect Medical Theme Index, covering three major segments of the medical sector, with over 30% weight in CXO, over 20% in AI medical, and nearly 50% in innovative drugs [2] - The ETF was launched on the Shanghai Stock Exchange and supports T+0 trading [2]